Top Markets
#1 Islamic Coin Islamic Coin +155.94%
#2 Siren Siren +37.14%
#3 Arowana Arowana +19.76%
#4 RedStone RedStone +15.44%
#5 Cysic Cysic +15.30%
#6 Venom Venom +14.04%
#7 OpenEden OpenEden +13.54%
#8 Nockchain Nockchain +12.74%
#9 Perle Perle +11.94%
#10 KUB Coin KUB Coin +11.87%
Coin of the day
Islamic Coin Islamic Coin
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Brainstorm Cell Therapeutics Inc. Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc.

BCLI
Rang în acțiuni #31763
Brainstorm Cell Therapeutics Inc. (BCLI) is a biotechnology firm dedicated to... Brainstorm Cell Therapeutics Inc. (BCLI) is a biotechnology firm dedicated to the development and commercialization of personalized, autologous cellular therapies. These innovative treatments are specifically designed to address neurodegenerative diseases. At the heart of its strategy is the proprietary NurOwn cell therapy platform. This platform employs sophisticated cell culture techniques to prompt mesenchymal stem cells, derived from the patient's own bone marrow, to produce high concentrations of neurotrophic factors. This process aims to regulate neuroinflammatory and neurodegenerative disease mechanisms, bolster the survival of neurons, and ultimately enhance neurological function. NurOwn is currently undergoing significant clinical development, having completed a Phase III clinical trial for Amyotrophic Lateral Sclerosis (ALS). Additionally, it has successfully advanced through Phase II clinical trials for both progressive multiple sclerosis and Alzheimer's disease, with potential applications being explored for other neurodegenerative conditions. To support its therapeutic pipeline, the company has established a manufacturing partnership with Catalent for NurOwn. Incorporated in 2000, the company initially operated as Golden Hand Resources Inc. before adopting the name Brainstorm Cell Therapeutics Inc. in November 2004. Its corporate headquarters are situated in New York, New York.
Preț acțiune
$1.10
Ultima sincronizare: 2026-08-17
Capitalizare de piață
$12.14M
Schimbare (1 zi)
11.11%
Schimbare (1 an)
77.42%
Țară
US
Tranzacționează Brainstorm Cell Therapeutics Inc. (BCLI)

Categorie

Healthcare
Venituri pentru Brainstorm Cell Therapeutics Inc. (BCLI)
Venituri în Aug 2026 TTM: 0
Conform celor mai recente rapoarte financiare ale Brainstorm Cell Therapeutics Inc., venitul actual al companiei (TTM) este 0. În anul 2026, compania a avut un venit de 0 egal cu venitul din anul 2026, care a fost de 0. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru Brainstorm Cell Therapeutics Inc. din 2026 până în 2026
Venituri la sfârșitul fiecărui an
An Venituri Schimbă
Nu sunt suficiente date pentru perioada selectată.
Venituri pentru companii similare sau concurente
Companie Venituri Diferență de venituri Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR